SupremeToday Landscape Ad
AI Thinking

AI Thinking...

Searching Case Laws & Precedent on Legal Query.....!

Analysing the retrieved Case Laws

Scanned Judgements…!


AI Overview

AI Overview...

  • Section 8 of the NDPS Act defines manufactured drugs and specifies which substances fall under the Act. Drugs not declared as manufactured drugs via official notification or not fitting the definition under Section 2(xi)(b) are not governed by the NDPS Act but may be regulated under the Drugs and Cosmetics Act. For example, drugs like coca leaf, cannabis, opium, and poppy straw are explicitly included, but substances outside these or not notified as manufactured drugs are excluded ["2023 0 Supreme(HP) 356"].

  • Application of the NDPS Act and Drugs and Cosmetics Act: Section 80 clarifies that the provisions of the NDPS Act can be applied in addition to the Drugs and Cosmetics Act, not in derogation of it. This means that cases involving drugs may involve both statutes depending on the nature of the substance and the specific violation ["2022 0 Supreme(Cal) 1254"], ["2022 0 Supreme(Del) 1905"].

  • Legal Proceedings and Offenses: Violations involving manufactured drugs, especially in bulk or without license, are typically prosecuted under Sections 8, 21, 22, 28, and 29 of the NDPS Act, which prescribe stringent punishments including rigorous imprisonment, especially for commercial quantities. Courts have held that possession of manufactured drugs in bulk without license falls squarely under NDPS provisions rather than the Drugs and Cosmetics Act ["2024 0 Supreme(AP) 1436"], ["2023 0 Supreme(Pat) 124"], ["2022 0 Supreme(Cal) 1254"].

  • Notification and Definition of 'Manufactured Drug': The Central Government must notify certain preparations as 'manufactured drugs' under Section 2(xi)(b). Only after such notification do these preparations qualify as 'manufactured drugs' within the NDPS framework, and consequently, all such drugs are included within the broader category of 'narcotic drugs' under Section 2(xiv). The term 'essential narcotic drugs' remains undefined in the Act ["

    Mohd. Ahsan vs Customs - Delhi

    "], ["2022 Supreme(Online)(DEL) 4188"], ["2021 Supreme(Online)(MP) 2821"].
  • Legal Interpretation and Court Rulings: Courts have consistently emphasized that unless a substance is notified as a 'manufactured drug' under the NDPS Act, possession or contravention may not be prosecuted under NDPS but could be under other applicable laws like the Drugs and Cosmetics Act. The courts have clarified that the mere possession of certain drugs does not automatically invoke NDPS provisions unless the substance qualifies as a 'manufactured drug' per the Act's definitions and notifications ["2023 0 Supreme(HP) 356"], ["2022 0 Supreme(Del) 1905"].

Conclusion: Under Section 8 of the NDPS Act, only substances explicitly notified or falling within the defined categories of 'manufactured drugs' are prosecutable under the NDPS framework. The Act's scope is supplemented by the Drugs and Cosmetics Act, and proper notification by the Central Government is essential to classify a preparation as a 'manufactured drug.' Offenses involving unnotified substances or those not fitting the statutory definitions are generally governed by other laws, and courts have upheld this interpretation in various rulings.

Prosecuting Manufactured Drug Violations Under NDPS Act Section 8 and Drugs & Cosmetics Act

NDPS Act Section 8: Navigating Rules on Manufactured Drugs

In India, the Narcotic Drugs and Psychotropic Substances (NDPS) Act, 1985, stands as a cornerstone in combating drug abuse and trafficking. A common query arises: Manufactured Drugs Ndps Act s 8 – does Section 8 criminalize all manufacture and possession of manufactured drugs, or are there exceptions? This blog post delves into the nuances, explaining prohibitions, exceptions for medicinal and scientific purposes, and real-world applications from judicial precedents. Note that this is general information; consult a legal expert for specific advice.

Understanding Section 8 of the NDPS Act

Section 8 of the NDPS Act prohibits the production, manufacture, possession, sale, purchase, transport, or dealing in narcotic drugs and psychotropic substances except for medical or scientific purposes and in accordance with the law2006 8 Supreme 747. The Act's primary goal is to control operations and prevent misuse, as enacted to consolidate laws on these substances 2025 7 Supreme 22.

Key takeaway: Legitimate activities under licensing are permissible, shielding compliant manufacturers and pharmacies from NDPS penalties 2006 8 Supreme 747.

Definition of 'Manufactured Drugs'

Under Section 2(xi), 'manufactured drug' includes coca derivatives, medicinal cannabis, opium derivatives, and poppy straw concentrate, subject to notifications and therapeutic limits 2011 0 Supreme(SC) 60. For instance, drugs with opium derivatives like codeine are allowed if they meet concentration limits specified in notifications, such as the one dated 14.11.1985 2011 0 Supreme(SC) 60.

Exceptions for Medicinal and Scientific Purposes

The Act explicitly carves out exceptions: manufacture and possession are lawful when compliant with licensing and used therapeutically. Courts have clarified that drugs within notified limits and proper authorization fall outside Section 8's criminal ambit 2006 8 Supreme 747 2011 0 Supreme(SC) 60.

  • Permitted activities: Licensed production, sale, and possession for medical use.
  • Conditions: Adherence to concentration limits, government notifications, and rules like the NDPS Rules.
  • Examples: Cough syrups with codeine or ayurvedic medicines with opium derivatives, if licensed 2011 0 Supreme(SC) 60.

Judicial pronouncements reinforce this: Activities for medicinal purposes under proper licensing are lawful, and emphasizes the distinction between lawful medicinal use and illicit trafficking 2006 8 Supreme 747.

When Does NDPS Section 8 Trigger Prosecution?

Prosecution applies when activities exceed limits, lack licensing, or serve illicit ends like trafficking. Bulk quantities or commercial intent signal violations 2011 0 Supreme(SC) 60.

Notifications define 'small quantity' and 'commercial quantity,' impacting penalties. For mixtures, only the narcotic component counts toward commercial quantity, excluding neutral substances like water or dextrose – a vital ruling to avoid absurd outcomes, such as jailing doctors for diluted injections 2018 0 Supreme(P&H) 1916.

If the interpretation as put forward by State Government is accepted... then such an interpretation would lead to disastrous and absurd results 2018 0 Supreme(P&H) 1916.

Interplay with Drugs and Cosmetics Act

Manufactured drugs by licensed producers are typically regulated under the Drugs and Cosmetics Act, 1940, not NDPS, unless in loose form (e.g., powder, liquid) indicating misuse 2019 0 Supreme(P&H) 300 2019 1 Supreme 92. The Supreme Court noted: manufactured drugs, be it containing narcotic drugs or psychotropic substances, if manufactured by a manufacturer, must be tried... under the Drugs and Cosmetics Act and not under the NDPS Act, except those in loose form 2019 1 Supreme 92.

Provisions aren't mutually exclusive; NDPS curbs intoxication, while Drugs Act handles therapeutic use 2019 1 Supreme 92. In State of Punjab vs Rakesh Kumar, dealing without a license violated both, denying bail 2019 0 Supreme(P&H) 300.

Judicial Insights from Key Cases

Courts consistently distinguish compliant medicinal use from crime:

  • Bail Denials: In a case with Alprazolam and Pseudoephedrine export without registration, bail was rejected due to large quantities and trafficking risks. Section 9A mandates unique registration for controlled substances 2023 0 Supreme(Mad) 2786.
  • Prima Facie Evidence: For Phensedyl Cough Syrup trafficking, mobile records sufficed to proceed under Sections 21/22, dismissing quash petitions 2024 0 Supreme(Cal) 1099.
  • Suspension of Sentence: High Court erred in suspending sentences for manufactured drugs violations under Section 8/21/22; prosecution is State's prerogative 2019 1 Supreme 92.
  • Ayurvedic Medicines: Possession without license led to bail denial, as NDPS applies strictly sans authorization 2019 0 Supreme(P&H) 300.
  • Commercial Quantity Nuances: Neutral substances don't count; precedents like E. Michael Raj bind courts 2018 0 Supreme(P&H) 1916.

In one bail grant, doubts on prosecution and clean record favored release under Sections 21/22/25 2022 0 Supreme(All) 1379.

Practical Recommendations for Compliance

To avoid NDPS pitfalls:

  • Verify licensing, concentration limits, and notifications.
  • Document medicinal intent; bulk holdings risk scrutiny.
  • Prosecute diversions under NDPS, legitimate use under Drugs Act.
  • Maintain records to prove compliance 2011 0 Supreme(SC) 60.

Authorities must check: whether the drugs involved are within the limits and conditions specified in notifications and whether proper licensing has been obtained 2011 0 Supreme(SC) 60.

Conclusion: Balancing Regulation and Legitimate Use

Section 8 prohibits manufactured drugs dealings sans exceptions, but safeguards medicinal/scientific use under strict compliance. Judicial trends emphasize evidence, licensing, and intent, preventing overreach while curbing trafficking. Businesses and professionals should prioritize documentation to navigate this stringent regime.

Key Takeaways:- Licensed medicinal drugs evade NDPS prosecution 2006 8 Supreme 747.- Violations, especially commercial quantities, attract severe penalties 2011 0 Supreme(SC) 60.- Consult notifications and counsel for clarity.

This post references judgments like 2025 7 Supreme 22, 2006 8 Supreme 747, 2011 0 Supreme(SC) 60, 2023 0 Supreme(Mad) 2786, 2024 0 Supreme(Cal) 1099, 2022 0 Supreme(All) 1379, 2019 0 Supreme(P&H) 300, 2019 1 Supreme 92, 2018 0 Supreme(P&H) 1916. It provides general insights, not legal advice.

#NDPSAct #ManufacturedDrugs #NarcoticsLaw
Chat Download
Chat Print
Chat R ALL
Landmark
Strategy
Argument
Risk
Chat Voice Bottom Icon
Chat Sent Bottom Icon
SupremeToday Portrait Ad
logo-black

An indispensable Tool for Legal Professionals, Endorsed by Various High Court and Judicial Officers

Please visit our Training & Support
Center or Contact Us for assistance

qr

Scan Me!

India’s Legal research and Law Firm App, Download now!

For Daily Legal Updates, Join us on :

whatsapp-icon Back to top